Myasthenia gravis trials in Latvia

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

  Where

  Riga

  Age

  18 years to 80 years

  People

  195 worldwide

  Run by

  Dianthus Therapeutics

  See details and how to joinNCT07647510 · EU 2026-525298-38-00